
Syneos Health SYNH
Quartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Syneos Health EV 2011-2026 | SYNH
EV Jährlich Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 14.1 B | 12.3 B | 10.7 B | 9.51 B | 6.89 B | 3.67 B | 3.35 B | 1.97 B | 860 M | 859 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.1 B | 859 M | 6.42 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 115.55 | 3.81 % | $ 35.1 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 20.81 | 0.05 % | $ 1.11 B | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.55 | 1.31 % | $ 2.06 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.49 | 1.03 % | $ 680 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.19 | 2.64 % | $ 459 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 118.33 | 1.86 % | $ 9.76 B | ||
|
Illumina
ILMN
|
15.3 B | $ 126.74 | 5.29 % | $ 20.2 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 166.97 | 1.91 % | $ 8.28 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 84.62 | 4.25 % | $ 5.71 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 418.66 | 1.23 % | $ 12.1 B | ||
|
Guardant Health
GH
|
15.2 B | $ 87.08 | 4.4 % | $ 10.9 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 26.34 | 2.95 % | $ 20 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.75 | 1.5 % | $ 440 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.98 | -0.5 % | $ 8.76 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 9.26 | 3.35 % | $ 1.19 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.18 | 0.93 % | $ 5.01 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 256.8 | -0.13 % | $ 21.4 B | ||
|
National Research Corporation
NRC
|
432 M | $ 16.46 | -0.48 % | $ 368 M | ||
|
Celcuity
CELC
|
5.57 B | $ 121.35 | 1.97 % | $ 5.67 B | ||
|
Natera
NTRA
|
5.53 B | $ 206.16 | 5.86 % | $ 20.3 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.4 | 4.33 % | $ 2.04 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 194.2 | 2.58 % | $ 21.6 B | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M | ||
|
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | ||
|
Exagen
XGN
|
78.4 M | $ 2.9 | 5.07 % | $ 62.5 M | ||
|
Precipio
PRPO
|
42.5 M | $ 30.9 | 3.21 % | $ 49.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 17.0 | 4.68 % | $ 179 M | ||
|
Personalis
PSNL
|
229 M | $ 5.52 | 9.52 % | $ 327 M |